NLS Pharmaceutics AG (NLSPW) — Cash Flow Quality Index

Latest as of March 2025: -49.75x

NLS Pharmaceutics AG (NLSPW) has a Cash Flow Quality Index of -49.75x as of March 2025. Operating cash flow of $-2.74 Million is below net income of $55.02K, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does NLS Pharmaceutics AG generate cash to assess how effectively this company generates cash.

Cash Flow Quality Index

-49.75x
Operating CF / Net Income

Operating Cash Flow

$-2.74 Million
USD

Net Income

$55.02K
USD

Data as of

Mar 2025
Most recent filing

Annual Cash Flow Quality Index for NLS Pharmaceutics AG (None–None)

Year-by-year earnings quality comparison for NLS Pharmaceutics AG. For live market cap and the full company financial profile, see NLSPW market cap overview.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.